Mechanisms of Thrombus Formation
The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Abstract
Hemostasis is the process that maintains the integrity of a closed, high-pressure circulatory system after vascular damage. Vessel-wall injury and the extravasation of blood from the circulation rapidly initiate events in the vessel wall and in blood that seal the breach. Circulating platelets are recruited to the site of injury, where they become a major component of the developing thrombus; blood coagulation, initiated by tissue factor, culminates in the generation of thrombin and fibrin. These events occur concomitantly (Figure 1A; also see Video, available with the full text of this article at www.nejm.org), and under normal conditions, regulatory mechanisms contain . . .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These endothelial mediators subserve functions as varied as local flow distribution,91 immune surveillance (in concert with perivascular cells),92 and hemostatic balance.93”
In the citing paper
“Fibrinolytic therapy helps in dissolving fibrins in occluded vessels and improving the tumor vasculature [32,33,34,35,36].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [35]
In the citing paper
“enhanced platelet reactivity and acute thrombotic occlusion of vessels are the proximate cause of myocardial infarction, stroke and the majority of deaths in patients with CVD36.”
From Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential (2018) · cites this paper as [36]
Citations
Cites
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., & Chaudhuri, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9265 · Cited by 5,074
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Vu, T.-K. H., Hung, D. T., Wheaton, V. I., & Coughlin, S. R. (1991) · Cell · doi:10.1016/0092-8674(91)90261-v · Cited by 2,970
Platelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135
An Enzyme Cascade in the Blood Clotting Mechanism, and its Function as a Biochemical Amplifier
MACFARLANE, R. G. (1964) · Nature · doi:10.1038/202498a0 · Cited by 1,119
Waterfall Sequence for Intrinsic Blood Clotting
Davie, E. W., & Ratnoff, O. D. (1964) · Science · doi:10.1126/science.145.3638.1310 · Cited by 1,113
The Roles of Protein C and Thrombomodulin in the Regulation of Blood Coagulation
Esmon, C. T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83649-3 · Cited by 1,046
Blood-borne tissue factor: Another view of thrombosis
Giesen, P. L. A., Rauch, U., Bohrmann, B., Kling, D., Roqué, M., Fallon, J. T., Badimon, J. J., Himber, J., Riederer, M. A., & Nemerson, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2311 · Cited by 991
Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Cotran, R. S., & Gimbrone, M. A. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.2.618 · Cited by 935
Research works printed but not linked: 4
- Semeraro N, 1983, Immunology, 50, 529
- Reinhardt C, 2008, J Clin Invest, 118, 1110
- Cho J, 2008, J Clin Invest, 118, 1123
- 1986, Lancet, 1, 397
Cited by
Items 301–400 of 1,000
Cellular microparticles in the pathogenesis of pulmonary hypertension
Amabile, N., Guignabert, C., Montani, D., Yeghiazarians, Y., Boulanger, C. M., & Humbert, M. J. C. (2012) · European Respiratory Journal · doi:10.1183/09031936.00087212 · Cited by 66
On the Activation of Integrin αIIbβ3: Outside-in and Inside-out Pathways
Mehrbod, M., Trisno, S. L., & Mofrad, M. R. K. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2013.07.055 · Cited by 66
Friso, S., Lotto, V., Choi, S., Girelli, D., Pinotti, M., Guarini, P., Udali, S., Pattini, P., Pizzolo, F., Martinelli, N., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2011-100195 · Cited by 74
Bond, C. W., Hackney, K. J., Brown, S. L., & Noonan, B. C. (2018) · Journal of Orthopaedic and Sports Physical Therapy · doi:10.2519/jospt.2019.8375 · Cited by 69
Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel
Bonnard, T., & Hagemeyer, C. E. (2015) · Journal of Visualized Experiments · doi:10.3791/52838 · Cited by 65
Mfoumou, E., Tripette, J., Blostein, M. D., & Cloutier, G. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.11.001 · Cited by 74
12-lipoxygenase activity plays an important role in PAR4 and GPVI-mediated platelet reactivity
Yeung, J., Apopa, P. L., Vesci, J., Stolla, M., Rai, G., Simeonov, A. M., Jadhav, A., Fernandez‐Perez, P., Maloney, D. J., Boutaud, O. G., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-01-0014 · Cited by 65
“Since dense granule is thought to be a major reinforcement pathway leading to secretion of platelet agonists such as ADP, 5-HT, and epinephrine (2, 40), 12-LOX inhibition of dense granule secretion may partially explain the observed deficit in normal platelet aggregation and adhesion as well as an inability to form st…”
BackgroundInfluentialEnterohemorrhagic Escherichia coli Pathogenesis and the Host Response
Karpman, D., & Ståhl, A.-L. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.ehec-0009-2013 · Cited by 71
“In parallel with the recruitment of platelets, the blood coagulation cascade is activated at the site of vessel injury (135).”
BackgroundCoagulopathy in trauma patients: importance of thrombocyte function?
Davenport, R. A., & Brohi, K. (2009) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e328325a6d9 · Cited by 65
Fuentes, H. E., Tafur, A. J., & Caprini, J. A. (2016) · Disease-a-Month · doi:10.1016/j.disamonth.2016.03.003 · Cited by 70
Cheng, S., Gu, Z., Zhou, L., Hao, M., An, H., Song, K., Wu, X., Zhang, K., Zhao, Z., Dong, Y., et al. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.765987 · Cited by 64
“Hemostatic stage Interconnection between blood vessels slows blood flow to the injured tissue and minimizes bleeding caused by the wound (Furie and Furie, 2008; Rodrigues et al., 2019).”
BackgroundMicroparticles, malignancy and thrombosis
Zahra, S., Anderson, J. A. M., Stirling, D., & Ludlam, C. A. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08452.x · Cited by 64
“Cell stimulation can also lead to the expression of TF on monocytes and endothelial cells (Furie & Furie, 2008).”
BackgroundEmerging roles of fibronectin in thrombosis
Maurer, L. M., Tomasini-Johansson, B. R., & Mosher, D. F. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2009.12.017 · Cited by 66
“Thrombus formation involves platelet adhesion, platelet activation and aggregation, and build-up of a fibrin-rich thrombus [46].”
Association of Aspirin Resistance With Increased Stroke Severity and Infarct Size
Zheng, A. S. Y., Churilov, L. P., Colley, R., Goh, C., Davis, S. M., & Yan, B. (2012) · JAMA Neurology · doi:10.1001/jamaneurol.2013.601 · Cited by 64
“Platelets are critical to thrombus formation, contributing as much as 50% of the total thrombus volume.(39) Antiplatelet agents decrease platelet aggregation and, in turn, the size and frequency of thrombolytic emboli.”
BackgroundMicroparticles in stored red blood cells: submicron clotting bombs?
Rubin, O., Crettaz, D., Tissot, J., & Lion, N. (2010) · PubMed · doi:10.2450/2010.006s · Cited by 80
Zhao, J., Bai, L., Ren, X., Guo, J., Xia, S., Zhang, W., & Feng, Y. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.07.057 · Cited by 65
Low-intensity focused ultrasound-augmented Cascade chemodynamic therapy via boosting ROS generation
Deng, L., Liu, M., Sheng, D., Luo, Y., Wang, D., Yu, X., Wang, Z., Ran, H., & Li, P. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120710 · Cited by 63
Cowan, P. J., & Robson, S. C. (2015) · International Journal of Surgery · doi:10.1016/j.ijsu.2015.07.682 · Cited by 63
“Coagulation is a tightly controlled physiological process designed to preserve the integrity of the vascular system [1].”
BackgroundTargeting GPVI as a novel antithrombotic strategy
Gardiner, E. E., Arthur, J. F., & Andrews, R. K. (2014) · Journal of Blood Medicine · doi:10.2147/jbm.s39220 · Cited by 63
“GPVI involvement in thrombosis In vascular lesions, where the endothelium has been denuded/ disrupted or there exists plaques, collagen as well as VWF are exposed and form a prothrombotic surface, a potent trigger for the platelet adhesion and aggregation.(2) Platelet engagement with the blood vessel wall is predomina…”
Comparison of two murine models of thrombosis induced by atherosclerotic plaque injury
Hechler, B., & Gachet, C. (2011) · Thrombosis and Haemostasis · doi:10.1160/ths10-11-0730 · Cited by 63
Hemostatic abnormalities in endocrine and metabolic disorders
Franchini, M., Lippi, G., Manzato, F., Vescovi, P. P., & Targher, G. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0958 · Cited by 64
Modelling of Blood Flow in Stenosed Arteries
Roy, M., Sikarwar, B. S., Bhandwal, M., & Ranjan, P. (2017) · Procedia Computer Science · doi:10.1016/j.procs.2017.09.164 · Cited by 66
Self-regulated hirudin delivery for anticoagulant therapy
Xu, X., Huang, X., Zhang, Y., Shen, S., Feng, Z., Dong, H., Zhang, C., & Mo, R. (2020) · Science Advances · doi:10.1126/sciadv.abc0382 · Cited by 62
“The main composition of the blood clot includes activated platelets, red blood cells (RBCs), and fibrins (7, 8).”
BackgroundIschemic Microenvironment‐Responsive Therapeutics for Cardiovascular Diseases
Li, X., Zhang, Y., Ren, X., Wang, Y., Chen, D., Li, Q., Huo, M., & Shi, J. (2021) · Advanced Materials · doi:10.1002/adma.202105348 · Cited by 65
Diseases Associated with Thrombosis
de Laforcade, A. M. (2012) · Topics in companion animal medicine · doi:10.1053/j.tcam.2012.07.002 · Cited by 62
Maugeri, N., Rovere, P. Q., Evangelista, V., Godino, C., Metrio, M. D., Baldini, M., Figini, F., Coppi, G., Slavich, M., Camera, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039484 · Cited by 62
“Platelet P-selectin expression was correlated with neutrophil activation, which in turn may contribute to thrombus formation [15,16,23].”
BackgroundMolecular Hemocompatibility of Graphene Oxide and Its Implication for Antithrombotic Applications
Kenry, K., Loh, K. P., & Lim, C. T. (2015) · Small · doi:10.1002/smll.201500841 · Cited by 64
Dangerous connections: neutrophils and the phagocytic clearance of activated platelets
Manfredi, A. A., Rovere, P. Q., & Maugeri, N. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283324f97 · Cited by 65
Microbial production of nattokinase: current progress, challenge and prospect
Cai, D., Zhu, C., & Chen, S. (2017) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-017-2253-2 · Cited by 62
“Thrombosis, a serious disease caused by the mass coagulation of fibrin and platelets, threatens human health, and is often related to some other diseases, such as stroke, cerebral and myocardial infarctions (Furie and Furie 2008; Kamiya et al. 2010).”
BackgroundKwon, H. J., Lee, Y., Phuong, L. T., Seon, G. M., Kim, E., Park, J., Yoon, H., & Park, K. D. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.08.007 · Cited by 62
Zhang, H., Qu, H., He, Q., Gao, L., Zhang, H., Wang, Y., Zhang, Z., & Hou, L. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.06.043 · Cited by 61
RetractedNanoplumbers: biomaterials to fight cardiovascular diseases
Dormont, F., Varna, M., & Couvreur, P. (2017) · Materials Today · doi:10.1016/j.mattod.2017.07.008 · Cited by 65
Chowdary, P. (2018) · Drugs · doi:10.1007/s40265-018-0922-6 · Cited by 62
“The blood haemostatic response initiated following damage to the vasculature results in thrombin generation, platelet activation and aggregation, enabling clot formation [39, 40].”
BackgroundMicroparticles (Exosomes) and Atherosclerosis
Chen, Y.-T., Yuan, H., Ou, Z., & Ou, J. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00841-z · Cited by 62
Kaiser, R. W. J., Escaig, R., & Nicolai, L. (2023) · Blood · doi:10.1182/blood.2023020535 · Cited by 69
Ivanciu, L., & Stalker, T. J. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13145 · Cited by 65
Microparticles and thrombotic disease
Davizon, P. D., & López, J. A. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32832ea49c · Cited by 67
Ouweneel, A. B., & Eck, M. V. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.10.009 · Cited by 62
Song, X., Xu, T., Li, Y., Li, Y., Yang, Y., Jin, L., Zhang, J., Zhong, R., Sun, S., Zhao, W., et al. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.9b01686 · Cited by 60
Nitric Oxide-Producing Cardiovascular Stent Coatings for Prevention of Thrombosis and Restenosis
Rao, J., Bei, H., Yang, Y., Liu, Y., Lin, H., & Zhao, X. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00578 · Cited by 62
“Intravascular injuries during surgical implantation stimulate coagulation pathways to facilitate platelet adhesion (Furie and Furie, 2008), and the production of thrombin further contributes to platelet activation and converses fibrinogen into fibrin-formed thrombus (Zhao et al.”
BackgroundFurie, B. (2009) · Hematology · doi:10.1182/asheducation-2009.1.255 · Cited by 60
Self-citationSpahn, D. R., Bouillon, B., Coats, T., Duranteau, J., Fernández‐Mondejar, E., Filipescu, D. C., Hunt, B. J., Nardi, G., Neugebauer, E. A. M., Riddez, L., et al. (2010) · Cited by 59
Platelet‐inspired nanomedicine in hemostasis thrombosis and thromboinflammation
Raghunathan, S. P., Rayes, J., & Gupta, A. S. (2022) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15734 · Cited by 59
Zhan, W., Shi, X., Yu, Q., Lyu, Z., Cao, L., Du, H. L., Liu, Q., Wang, X., Chen, G., Li, D., et al. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201501642 · Cited by 61
Recombinant tissue plasminogen activators (rtPA): A review
Gurman, P., Miranda, O. R., Nathan, A., Washington, C., Rosen, Y., & Elman, N. M. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.33 · Cited by 59
Prothrombin Complex Concentrate for Critical Bleeding
Patanwala, A. E., Acquisto, N. M., & Erstad, B. L. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1q096 · Cited by 59
Universal behavior of hydrogels confined to narrow capillaries
Li, Y., Sarıyer, O. S., Ramachandran, A., Panyukov, S., Rubinstein, M., & Kumacheva, E. (2015) · Scientific Reports · doi:10.1038/srep17017 · Cited by 59
Lee, J., Jeong, L., Jung, E., Ko, C., Seon, S., Noh, J., & Lee, D. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.05.012 · Cited by 60
Wang, H., Chen, L., Yang, B., Du, J. C., Chen, L., Li, Y., & Guo, F. (2023) · Nutrients · doi:10.3390/nu15081947 · Cited by 67
“Thrombosis is a critical event in diseases correlated with atherosclerosis, myocardial infarction, and stroke [198].”
BackgroundProthrombotic mechanisms and anticoagulant therapy in dogs with immune‐mediated hemolytic anemia
Kidd, L. B., & Mackman, N. (2013) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/j.1476-4431.2012.00824.x · Cited by 58
The effects of nanomaterials on blood coagulation in hemostasis and thrombosis
Šimák, J., & Paoli, S. D. (2017) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1448 · Cited by 68
Platelet activation and prothrombotic properties in a mouse model of peritoneal sepsis
Bounes, F. V., Mémier, V., Marcaud, M., Jacquemin, A., Hamzeh‐Cognasse, H., Garcia, C., Series, J., Siè, P., Minville, V., Gratacap, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31910-8 · Cited by 60
Review: Platelet Function Testing and Implications for Clinical Practice
Collet, J., & Montalescot, G. (2009) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248409339309 · Cited by 59
“The receptors mediating platelet activation create a positive feedback mechanism through the activation of G protein-mediated signaling pathways, further amplifying these prothrombotic signals in the creation of a growing thrombus.(3,9) Antiplatelet agents target different platelet activation pathways to inhibit plate…”
BackgroundRedox control of β2‐glycoprotein I–von Willebrand factor interaction by thioredoxin‐1
Passam, F. H., Rahgozar, S., QI, M., Raftery, M. J., Wong, J. W. H., Tanaka, K., Ioannou, Y., Zhang, J. Y., Gemmell, R., QI, J. C., et al. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03944.x · Cited by 57
Ogawa, S., Ohnishi, T., Hosokawa, K., Szlam, F., Chen, E. P., & Tanaka, K. A. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet229 · Cited by 58
Molecular Imaging of Atherosclerosis with Nanoparticle-Based Fluorinated MRI Contrast Agents
Palekar, R. U., Jallouk, A. P., Lanza, G. M., Pan, H., & Wickline, S. A. (2015) · Nanomedicine · doi:10.2217/nnm.15.26 · Cited by 59
Cheng, J., Feng, S., Han, S., Zhang, X., Chen, Y., Zhou, X. W., Wang, R., Li, X., Hu, H., & Zhang, J. (2016) · ACS Nano · doi:10.1021/acsnano.6b04124 · Cited by 57
Selection and characterization of a DNA aptamer inhibiting coagulation factor XIa
Donkor, D. A., Bhakta, V., Eltringham‐Smith, L. J., Stafford, A. R., Weitz, J. I., & Sheffield, W. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-02055-x · Cited by 57
“For rounds in which only positive selection was employed, biotinylated anti-FXIa antibodies and streptavidin-coated magnetic beads (1) were combined with FXIa (2) and the original aptamer library (3).”
Porcine genome engineering for xenotransplantation
Niu, D., Ma, X., Yuan, T., Niu, Y., Xu, Y., Sun, Z., Yuan, P., Li, W., Zhang, J., Wang, T., et al. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.04.001 · Cited by 77
Quercitrin inhibits platelet activation in arterial thrombosis
Oh, T. W., Ju, H., Jeon, J., & Kim, K. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153363 · Cited by 57
Zhao, R., Ning, X., Wang, M., Wang, H., Xing, G., Wang, L., Lu, C., Yu, A., & Wang, Y. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c02354 · Cited by 58
Kondo, R., Yano, H., Nakashima, O., Tanikawa, K., Nomura, Y., & Kage, M. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0656-2 · Cited by 56
“The disrupted endothelium is the first reaction in platelet adhesion to the vessel subendothelium under physiologic blood flow [33].”
BackgroundPutting polyphosphates to the test: evidence against platelet-induced activation of factor XII
Faxälv, L., Boknäs, N., Ström, J. O., Tengvall, P., Theodorsson, E., Ramström, S., & Lindahl, T. L. (2013) · Blood · doi:10.1182/blood-2013-05-499384 · Cited by 66
Nanofibrous polymeric beads from aramid fibers for efficient bilirubin removal
Peng, Z., Yang, Y., Luo, J., Nie, C., Ma, L., Cheng, C., & Zhao, C. (2016) · Biomaterials Science · doi:10.1039/c6bm00328a · Cited by 56
Ntelis, K., Solomou, E. E., Sakkas, L. I., Liossis, S. C., & Daoussis, D. (2017) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2017.05.004 · Cited by 58
Urokinase Plasminogen Activator: A Potential Thrombolytic Agent for Ischaemic Stroke
Kadir, R. R. A., & Bayraktutan, U. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00737-w · Cited by 56
“Exposed collagen binds to circulating von Willebrand factor (vWF), which subsequently binds to platelet through GP1b-IX-V receptor, leading to the formation of the collagen-vWF-GP1b-IX-V axis, a key step for the initial attachment of platelets (Furie and Furie 2008).”
BackgroundPrinz, N., Clemens, N., Canisius, A., & Lackner, K. J. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-06-0421 · Cited by 58
“The basic principles of the initiation of clot formation by TF and the physiologic control of this process have been reviewed extensively (1, 2).”
BackgroundPaired immunoglobulin-like receptor B regulates platelet activation
Fan, X., Shi, P., Dai, J., Lu, Y., Chen, X., Liu, X., Zhang, K., Wu, X., Sun, Y., Wang, K., et al. (2014) · Blood · doi:10.1182/blood-2014-03-557645 · Cited by 57
Solouk, A., Cousins, B. G., Mirahmadi, F., Mirzadeh, H., Nadoushan, M. J., Shokrgozar, M. A., & Seifalian, A. M. (2014) · Materials Science and Engineering C · doi:10.1016/j.msec.2014.10.065 · Cited by 55
Current and future perspectives in imaging of venous thromboembolism
Dronkers, C. E. A., Klok, F. A., & Huisman, M. V. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13403 · Cited by 60
Differentiating haemostasis from thrombosis for therapeutic benefit
McFadyen, J. D., & Jackson, S. P. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-05-0379 · Cited by 60
“Thrombin generation at the site of endothelial injury is initiated by the exposure of tissue factor, which then forms a catalytic complex with factor VIIa, initiating the ‘extrinsic’ pathway of blood coagulation (25).”
BackgroundPeptide-based fibrin-targeting probes for thrombus imaging
Oliveira, B. L., & Caravan, P. (2017) · Dalton Transactions · doi:10.1039/c7dt02634j · Cited by 51
Lo, R. W., Li, L., Leung, R., Pluthero, F. G., & Kahr, W. H. A. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311270 · Cited by 61
Wu, Y., Zhang, R., Nguyen, D. H. T., Kurniawan, N. D., Moonshi, S. S., Whittaker, A. K., & Ta, H. T. (2021) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c00141 · Cited by 57
Current evidence and clinical implications of aspirin resistance
Kasotakis, G., Pipinos, I. I., & Lynch, T. G. (2009) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2009.06.023 · Cited by 54
Platelets in Atherosclerosis and Thrombosis
Schulz, C., & Maßberg, S. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-29423-5_5 · Cited by 53
Point-of-Care Technologies for Precision Cardiovascular Care and Clinical Research
King, K. R., Grazette, L. P., Paltoo, D. N., McDevitt, J. T., Sia, S. K., Barrett, P. M., Apple, F. S., Gurbel, P. A., Weissleder, R., Leeds, H. S., et al. (2016) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2016.01.008 · Cited by 65
“Examples include clot relaxation (27) or thromboelastography (16), which evaluate viscoelastic properties of clot formation.”
BackgroundAlteration of blood clot structures by interleukin-1 beta in association with bone defects healing
Wang, X., Friis, T., Masci, P. P., Crawford, R., Liao, W., & Xiao, Y. (2016) · Scientific Reports · doi:10.1038/srep35645 · Cited by 58
Aharon, A., Katzenell, S., Tamari, T., & Brenner, B. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03342.x · Cited by 53
Falanga, A. (2009) · Cancer Investigation · doi:10.1080/07357900802563028 · Cited by 53
“It has also recently been reported that circulating tissue-factor-rich particles derived from tumors may be involved in the induction of cancerassociated thrombosis (31).”
BackgroundClinical significance of neutrophil extracellular traps biomarkers in thrombosis
Xu, X., Wu, Y., Xu, S., Yin, Y., Ageno, W., Stefano, V. D., Zhao, Q., & Qi, X. (2022) · Thrombosis Journal · doi:10.1186/s12959-022-00421-y · Cited by 60
Lee, D. U., Kayumov, M., Park, J., Park, S. K., Kang, Y., Ahn, Y., Kim, W., Yoo, S. H., Park, J., Kim, B., et al. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.12.009 · Cited by 52
Cell-Derived Microparticles: New Targets in the Therapeutic Management of Disease
Bebawy, M., Roseblade, A., Luk, F., Rawling, T., Ung, A. T., & Grau, G. E. (2013) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3989x · Cited by 56
“This capacity has been implicated in long range cell signaling, coagulation, apoptosis, immune modulation, drug resistance and disease (19-24).”
Microparticles as Biomarkers of Venous Thromboembolic Events
Campello, E., Spiezia, L., Radu, C. M., & Simioni, P. (2016) · Biomarkers in Medicine · doi:10.2217/bmm-2015-0063 · Cited by 53
A shear-dependent NO-cGMP-cGKI cascade in platelets acts as an auto-regulatory brake of thrombosis
Wen, L., Feil, S. C., Wolters, M., Thunemann, M., Regler, F., Schmidt, K., Friebe, A., Olbrich, M., Langer, H. F., Gawaz, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06638-8 · Cited by 55
Pircher, J., Fochler, F., Czermak, T., Mannell, H., Kraemer, B. F., Wörnle, M., Sparatore, A., Soldato, P. D., Pohl, U., & Krötz, F. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300627 · Cited by 52
Ramacciotti, E., Myers, D. D., Wrobleski, S. K., Deatrick, K. B., Londy, F. J., Rectenwald, J. E., Henke, P. K., Schaub, R. G., & Wakefield, T. W. (2009) · Thrombosis Research · doi:10.1016/j.thromres.2009.10.022 · Cited by 52
Thrombolytic Agents: Nanocarriers in Targeted Release
Shen, M., Wang, Y., Hu, F., Lv, L., Chen, K., & Xing, G. (2021) · Molecules · doi:10.3390/molecules26226776 · Cited by 51
“This process is called thrombosis and the solid matter is known as a thrombus [1,2].”
BackgroundKhanna, S., Das, A., Spieldenner, J. M., Rink, C. L., & Roy, S. (2015) · Journal of Medicinal Food · doi:10.1089/jmf.2014.0178 · Cited by 61
“the pathogenesis of atherosclerosis and in acute thrombotic events.(21) Accordingly, increased platelet aggregation is yet another major risk factor for CVD.”
BackgroundMontague, S. J., Lim, Y. J., Lee, W. M., & Gardiner, E. E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00078 · Cited by 57
“If the rheological conditions are altered such that non-laminar disrupted flow is present, platelet activation is also immediately triggered (36, 44, 45).”
BackgroundJin, Y., Zhu, Z., Liang, L., Lan, K., Zheng, Q., Wang, Y., Guo, Y., Zhu, K., Mehmood, R., & Wang, B. (2020) · Applied Surface Science · doi:10.1016/j.apsusc.2020.146539 · Cited by 54
Association of the platelet GPIIb/IIIa polymorphism with atherosclerotic plaque morphology
Kucharska‐Newton, A., Monda, K. L., Campbell, S., Bradshaw, P. T., Wagenknecht, L. E., Boerwinkle, E., Wasserman, B. A., & HEISS, G. M. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.01.038 · Cited by 51
“Platelet aggregation is an essential step in formation of the thrombus [7] and in subsequent blood vessel wall remodeling [8].”
Complement and coagulation crosstalk – Factor H in the spotlight
Heurich, M., & McCluskey, G. (2023) · Immunobiology · doi:10.1016/j.imbio.2023.152707 · Cited by 55
“Factor V is activated by the first thrombin in circulation however it can also be activated by FXa on the surface of platelets (Bruce Furie and Furie, 2008; Smith et al., 2015).”
Social connectedness is associated with fibrinogen level in a human social network
Kim, D. A., Benjamin, E. J., Fowler, J. H., & Christakis, N. A. (2016) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2016.0958 · Cited by 48
Johnson, S., Duffy, S., Gunning, G. M., Gilvarry, M., McGarry, P., & McHugh, P. E. (2017) · Annals of Biomedical Engineering · doi:10.1007/s10439-017-1906-5 · Cited by 50
Cardiovascular effects of airborne particulate matter: A review of rodent model studies
Hadei, M., & Naddafi, K. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.125204 · Cited by 50
Wu, W., Zhussupbekov, M., Aubry, N., Antaki, J. F., & Massoudi, M. (2019) · International Journal of Engineering Science · doi:10.1016/j.ijengsci.2019.103206 · Cited by 50
“However, pathological formation of blood clots (thrombosis) is responsible for many cardiovascular disorders and malfunction of blood-wetted medical devices (Furie & Furie, 2008; Handin, 2005; Stalker et al., 2013).”
BackgroundIn situ Pulmonary Artery Thrombosis: A Previously Overlooked Disease
Cao, Y., Geng, C., Li, Y., & Zhang, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.671589 · Cited by 52
“Endothelial cells also generate nitric oxide, prostacyclin, and ectonucleotidase CD39, which can prevent platelet activation and inhibit coagulation (Furie and Furie, 2008).”
BackgroundInfluentialControl of Mature Protein Function by Allosteric Disulfide Bonds
Azimi, I., Wong, J. W. H., & Hogg, P. J. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3620 · Cited by 50
“Unwanted thrombosis is the precipitating event in myocardial infarction and stroke, whereas venous thrombosis is the second leading cause of death in patients with cancer (25).”
Anti-thrombosis effect of diosgenyl saponins in vitro and in vivo
Zhang, R., Huang, B., Du, D., Guo, X., Xin, G., Xing, Z., Liang, Y. K., Chen, Y., Chen, Q., He, Y., et al. (2013) · Steroids · doi:10.1016/j.steroids.2013.07.003 · Cited by 50
“Thrombosis is the formation or presence of a blood clot in a blood vessel, obstructing the flow of blood through the circulatory system [1].”
Background
Metadata
- Authors
- Furie, B., & Furie, B. C.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- ORCID
- Furie, Bruce
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-08-28
- Volume
- 359
- Issue
- 9
- Pages
- 938-949
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1983760732
- Cited by
- 1,926
- References
- 122
- Citations by year
- 2026: 75 · 2025: 119 · 2024: 114 · 2023: 121 · 2022: 110 · 2021: 117 · 2020: 103 · 2019: 96 · 2018: 93 · 2017: 109 · 2016: 108 · 2015: 122 · 2014: 101 · 2013: 119 · 2012: 106
- FWCI
- 13.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL087203)
- Topics
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Keywords
- thrombus formation, hemostasis, platelet recruitment, coagulation, tissue factor, thrombin, fibrin, vascular injury, coagulation regulation
- MeSH terms
- Animals, Blood Coagulation, Blood Coagulation Disorders, Fibrinolytic Agents, Humans, Neoplasms, Thrombosis, Platelet Activation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.